Compliance Across Life Sciences Industries: Enabling Innovation Through Quality and Regulatory Excellence
Innovation moves quickly, but compliance remains essential to bringing safe and effective new drugs and products to market.
Join senior industry leaders for a cross-sector discussion on how organizations are approaching compliance in today's rapidly changing environment. Through practical examples and real-world experiences, panelists will explore both the similarities and differences in regulatory strategies across life sciences sectors such as biopharma, regulated cannabis, medical technology. The discussion will highlight how organizations can strengthen quality systems, manage risk, support innovation, and maintain regulatory readiness throughout the product lifecycle.
Key discussion topics include:
Building a culture of quality beyond regulatory compliance
Managing risk while accelerating innovation
Lessons that different sectors can learn from one another
Preparing organizations for future regulatory and market expectations
Whether you work in established industry, research, startup or government, this session will provide valuable insights into how compliance can serve as a strategic enabler of innovation, growth, and public confidence.
The session will conclude with an interactive discussion and audience Q&A, providing attendees with an opportunity to share experiences and engage directly with panelists.
Moderator: Fatou Pompilus-T., P.Eng. - LAPORTE Consultants
Speakers:
Jonathan Fok, Co-Founder & Director of Operations - Bennu Product Development
Chris Mayerson, Chief Executive Officer - Black Rock Cannabis Company
Becki Hiebert, Quality and Regulatory leader
Others to be annouced.